ArticleHuman vaccines & immunotherapeutics2024
Establishment of potent TCR-T cells specific for cisplatin-resistance related tumor-associated antigen, CLSPN using codon-optimization.
Kanta Hori et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.